Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies. - Kerns SJ; Belgur C; Petropolis D; Kanellias M; Barrile R; Sam J; Weinzierl T; Fauti T; Freimoser-Grundschober A; Eckmann J; Hage C; Geiger M; et al. (ELife, 2021)